Welcome to BCIQ: BioCentury Online Intelligence.
Free access to this and other abridged company profiles is provided to all subscribers to SciBX: Science-Business eXchange.

Please explore the profile and if you wish to find out more about BCIQ - please Click Here

Biotest AG

Print preview

(Xetra:BIO)

General Information

Location	Dreieich, Germany
Region
Country	Germany
Business Category	Supply/Service, Diagnostic
Year Founded	1946
Website	www.biotest.com
Development Status	Market (tools & services) (04/18/2007)

Archive Items are loading

Financial Information

Financing Summary

Total Money Raised	Number of Completed Financings	Last Financing Date	Last Financing Type	Number of All Financings
$38,131,720	1	10/31/2005	Rights offering (other)	1

Financing Details

Company Name	Financing Status	Date Completed	Financing Type	Amount Raised	Share Price	Post-Money Valuation
Biotest AG	Completed	10/31/2005	Rights offering (other)	$38,131,720		$0

Financial Performance Summary

	1Q08	2Q08	3Q08	4Q08	1Q09
As Of Date	03/31/2008	06/30/2008	09/30/2008	12/31/2008	03/31/2009
Profit and loss
Sales	$0	$0	$0	$0	$0
Revenues	$166,742,750	$165,983,920	$161,143,750	$140,857,995	$158,527,380
SG&A	$42,989,600	$46,771,560	$45,137,500	$18,342,147	$43,017,480
R&D	$17,859,650	$17,322,800	$11,356,250	$18,990,379	$13,940,850
Operating Income	$21,020,650	$22,519,640	$23,431,250	$16,542,599	$19,118,880
Net Income	$10,431,300	$12,283,440	$11,931,250	$6,823,346	$10,223,290
EPS	$0.82	$0.94	$0.95	$0.55	$0.80
Diluted EPS	$0.82	$0.94	$0.95	$0.55	$0.80
Shares Outstanding	12,962,000	13,000,000	12,756,000	11,729,000	12,833,000
Balance Sheet
Cash	$20,230,400	$10,708,640	$16,243,750	$11,375,062	$11,816,530
Valuations
Market Cap	$777,411,504	$1,099,885,325	$883,461,404	$910,882,350	$494,581,253
Tech Value	$757,181,104	$1,089,176,685	$867,217,654	$899,507,288	$482,764,723
R&D/Sales
R&D/Revenue	0.11	0.10	0.07	0.13	0.09
SG&A/Sales
SG&A/Revenue	0.26	0.28	0.28	0.13	0.27
Currency Rate
Rate	1.5805	1.5748	1.4375	1.4092	1.3277

Stocks Annual Chart

Pipeline Information

Pipeline Summary

Disease Category	Research	Phase I	Phase I/II	Phase II	Phase II/III	Phase III	Registration	Approved	Marketed
Autoimmune	1	-	-	2	-	-	-	-	-
Cancer	-	1	-	-	-	-	-	-	-
Hematology	-	-	-	-	-	-	-	1	-
Infectious	-	-	-	1	-	-	-	1	3
Total	1	1	-	3	-	-	-	2	3

Pipeline Details - Originated and out-licensed products (10 records)

Product Names	Disease Category	Standard Indication	Partners	Milestones	Latest Stage of Development
BT-061 (Compound #)	Autoimmune	Psoriasis			Phase II
BT-061 (Compound #)	Autoimmune	Rheumatoid arthritis (RA)			Phase II

Pipeline Details - In-licensed products

ACCESS TO BIOCENTURY ONLINE INTELLIGENCE (BCIQ) AND THE BIOCENTURY ARCHIVES IS LIMITED ONLY TO AUTHORIZED SUBSCRIBERS WHO HAVE READ AND AGREED TO THE BIOCENTURY USER AGREEMENT, WHICH SOLELY GOVERNS THE CONDITIONS FOR USE OF ANY OF THESE SERVICES AND THE INFORMATION CONTAINED THEREIN. All contents Copyright © 1994-2009 BioCentury Publications, Inc. ALL RIGHTS RESERVED. These Services and the Content contained therein are protected under U.S. and foreign copyright and intellectual property laws, and may not be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions at www.biocentury.com. BioCentury®; The Bernstein Report on BioBusiness®; Because Real Intelligence is Hard to Find™; BCIQ™; The BioCentury 100™; and The Clear Route to ROI™ are trademarks of BioCentury Publications, Inc., P.O. Box 1246 San Carlos, CA 94070.